About

About GLP Chart

Independent comparison site for US weight loss telehealth programs. We rank 25 programs against the same five criteria every Monday and publish what we find. No paid placements, no preferred partners, no content reviewed by programs before publication.

Why this site exists

In 2024 GLP-1 prescribing through US telehealth went from a niche category to one of the fastest-growing consumer-healthcare markets in the country. Twenty-plus programs launched, each with their own pricing structure, their own lock-in terms, their own definition of what “included” means. Patients shopping cash-pay GLP-1 are forced to compare across formats that are deliberately incomparable. The comparison sites that existed at the time were either thinly disguised affiliate funnels that ranked whoever paid the highest commission, or were operated by the programs themselves under different brand names.

GLP Chart was built to be the honest scoreboard. Every program in the chart is scored the same way against the same five criteria. We accept affiliate revenue, disclosed on every page, but the rank order is determined before we touch a partnership conversation. Programs do not see their score before we publish it. We do not change scores in response to partnership outreach.

Who runs this

John Samaras, founder and editor of GLP Chart

John Samaras, founder and editor. Full-time on the US GLP-1 telehealth category since 2026. Based in Austin, Texas. Prior background: consumer product analysis and SaaS. No equity, no retainer, no referral arrangement with any program in the chart. The full editorial team is one person; the medical-review function is being actively recruited as of mid-2026 (see below).

LinkedIn · hello@glpchart.com · press@glpchart.com

Contact: hello@glpchart.com for general, press@glpchart.com for press and partnership.

How we score

Five dimensions, ten points each, weighted equally. The overall score is the simple average. Same scoring applied to every program in the chart, no exceptions, no weighted favorites. The five dimensions:

  1. Pricing transparency. All costs published in advance, ongoing rates separated from introductory rates, lab and setup fees disclosed.
  2. Cancellation terms. Lock-in periods scored honestly. Self-serve cancellation rewarded. Phone-only cancellation flagged. Non-refundable upfront fees called out.
  3. Onboarding experience. Time from intake to first prescription. Quality of clinical assessment. Synchronous vs asynchronous visits.
  4. Medication options. Branded availability, compounded availability, insurance pathway, dose flexibility.
  5. Member outcomes. Verified-member feedback weighted above marketing copy. We read Trustpilot, Reddit and program-specific community feedback for every program.

Full methodology, including how each dimension is operationalised: read the scoring methodology.

How we verify prices

Prices are pulled from each program's public-facing pricing page weekly and verified through anonymous purchase-flow walkthroughs. We sign up, complete the intake, take the medication and observe what actually appears on the receipt. The purchase-flow walkthrough is the single most expensive thing we do (real money out the door, every quarter, on every program). It is also the most defensible: most comparison sites copy pricing from the homepage of each program and miss the price-at-titration step.

See the quarterly Price Index for the per-program breakdown and the unit-cost (per milligram) analysis.

How we make money

We accept affiliate commissions on outbound clicks to partner programs. The commission does not affect scoring, rank order or editorial content. Programs are not told their score before publication. We do not accept paid placement. We do not run sponsored content. We do not charge programs for inclusion in the chart.

If you are a reader: every “Visit” link in the chart that earns us a commission is labeled with rel="sponsored"for FTC compliance and Google's link policy. You can also see the full affiliate disclosure.

Medical review (actively recruiting)

GLP Chart is editorial, not medical. We do not dispense, prescribe or fulfill medications. Everything on the site is for educational purposes.

We are actively recruiting a credentialed medical reviewer (PA, NP, RN, PharmD or MD with obesity-medicine experience) to review every drug, program and clinical-content page. When that reviewer is in place, every applicable page will carry a “Medically reviewed by” strap naming the clinician and their credential. Until then, treat clinical claims on the site as sourced and cited but not personally verified by a licensed clinician.

If you are a US-licensed obesity-medicine clinician interested in the reviewer role:
  • Scope: review and sign off on /drugs/, /program/, and clinical-content /learn/ pages. Roughly 4-8 hours per month after the initial onboarding pass.
  • Compensation: monthly retainer (commensurate with credential level) plus optional equity in the LLC for the right candidate.
  • What you get: a public byline on every page you review, a profile page on the site and the chance to shape the editorial standards of the largest independent GLP-1 comparison site in the US.
  • What we ask: active US licensure, no current employment relationship with any program in the chart, willingness to put your name and credentials on the work.
  • Contact: hello@glpchart.com with your CV/CV-equivalent and a paragraph on your obesity-medicine experience.

Editorial disclosure

GLP Chart is an editorial comparison site. We are not a medical provider, telehealth platform, or pharmacy. Information on this site is for educational purposes only and is not medical advice. Consult a licensed healthcare professional before making any treatment decisions. We may earn a commission when you click a partner link, at no cost to you. This does not affect our independent ratings. Updated May 25.

Why you can trust GLP ChartSame scoring framework applied to every program. No paid placements. No removal of unfavorable information at advertiser request. Pricing is pulled from each program's public-facing page weekly.